Searched for
EMA DRUG APPROVAL DELAY
Man booked 11 shops for Rs 25 lakh in Mumbai in 1995 but didn't get possession even after 30 years; he fights back and wins full refund with 12% interestOver 30 years ago in 1995, Amish Anantrai Modi had booked some shops in a project for a total consideration of Rs 25 lakh. In his complaint...- Stock Radar: Star Health stock breaks out from multi-year resistance band to hit fresh 52-week high in June; time to buy?Star Health and Allied Insurance has surged past a significant multi-year resistance, hitting a fresh 52-week high. Experts suggest this br...
- Stocks in news: Bajaj Auto, ZEE, BPCL, HDFC Bank, HUL, Tata Motors CVIndian markets saw a subdued trading session on Monday, with key indices declining due to mixed global signals and profit-taking. Several p...
- Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval,...
- Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent SystemsIndian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...
- Why clean land records are key to India's property marketStates are rapidly digitizing land records to streamline India's complex property market. This move aims to curb disputes, speed up transac...
- Homebuyer paid for a flat in a Delhi housing society in 2003, got delayed possession, sought compensation for delay; SC defends his rightThe SC said that the homebuyer can make a claim for compensation for delayed possession. “The subsequent receipt of possession cannot, by i...
- Manipur CM says drug trafficking routes have changed after 2023 crisis, largely diverting through MizoramManipur Chief Minister Yumnam Khemchand Singh revealed that drug trafficking routes have shifted significantly post-2023 crisis, largely di...
- Cabinet Secretariat cracks down on red tape, orders faster clearances for Centre's key projectsThe Cabinet Secretariat is pushing for faster government processes and reduced red tape to expedite key central projects. New directives ai...
- Homebuyer wins full refund with Rs 1.57 crore interest in MahaREAT as builder delays possession by 3 years, citing MHADA-MCGM disputeHomebuyers have won a significant victory as MahaREAT ruled a builder cannot use inter-authority disputes to justify possession delays exce...
- Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...
- Govt to amend NDPS Act to plug loopholes exploited by narco syndicates: Amit ShahUnion Home Minister Amit Shah announced plans to amend the NDPS Act to combat drug syndicates, emphasizing a strict approach against peddle...
- Lupin gets USFDA tentative approval for prostate cancer treatment drugIndian pharmaceutical giant Lupin Ltd has secured tentative approval from the US FDA for its generic enzalutamide tablets, a crucial treatm...
- CDSCO asks states, port offices to step up screening to curb imports of illegal drugsIndia's drug regulator is intensifying border screenings to block unapproved medicines from entering the country. Authorities are cracking ...
- EMA Partners India acquires digital RPO services provider Taggd in Rs 95 crore all-cash dealEMA Partners India has acquired Taggd, a digital RPO provider, for Rs 95 crore in an all-cash deal. This strategic move integrates executiv...
- Stocks in news: Vedanta, Honasa Consumer, IRCTC, Bajaj Auto, Tata MotorsIndian markets experienced profit booking, falling over a percent amidst a weak global trend. Key stocks like Vedanta, Honasa Consumer, IRC...
- Indian pharma firms gear up to supply key cancer drug to USIndian drugmakers are stepping up to help the US combat a critical shortage of ifosfamide injection, a vital chemotherapy drug. Leading com...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
Load More
